Literature DB >> 6754121

Studies on serum requirements for the cultivation of Plasmodium falciparum. 1. Animal sera.

A A Divo, J B Jensen.   

Abstract

Pooling a number of freshly collected lots of human serum eliminated the variability observed between individual serum samples, and reduced the amount of human serum required for optimum parasite growth in continuous culture. In the present experiments the addition of 50 ml of pooled human serum per litre of RPMI (5% serum) resulted in optimum growth. Batches of RPMI 1640 supplemented with freshly collected and pooled lots of bovine, porcine, goat, equine, or ovine sera, as well as commercially available fetal-and young-calf sera, were tested and compared with 5% pooled human serum. Various combinations of animal sera with and without Neopeptone were also examined as supplements to the basic culture medium. As an alternative to human serum, only bovine serum supplemented with Neopeptone could support continuous parasite growth, but at significantly reduced levels. Continuous parasite growth was obtained by transferring parasites directly from 5% human serum into medium plus freshly collected, Neopeptone-supplemented, pooled bovine serum, without any need for an adaptation period.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6754121      PMCID: PMC2536078     

Source DB:  PubMed          Journal:  Bull World Health Organ        ISSN: 0042-9686            Impact factor:   9.408


  5 in total

1.  Plasmodium falciparum in culture: use of outdated erthrocytes and description of the candle jar method.

Authors:  J B Jensen; W Trager
Journal:  J Parasitol       Date:  1977-10       Impact factor: 1.276

2.  Quality control studies on fetal bovine serum used in tissue culture.

Authors:  C W Boone; N Mantel; T D Caruso; E Kazam; R E Stevenson
Journal:  In Vitro       Date:  1971 Nov-Dec

3.  Peptones and calf serum as a replacement for human serum in the cultivation of Plasmodium falciparum.

Authors:  T Ifediba; J P Vanderberg
Journal:  J Parasitol       Date:  1980-04       Impact factor: 1.276

4.  Plasmodium falciparum in culture: establishment of additional strains.

Authors:  J B Jensen; W Trager
Journal:  Am J Trop Med Hyg       Date:  1978-07       Impact factor: 2.345

5.  Human malaria parasites in continuous culture.

Authors:  W Trager; J B Jensen
Journal:  Science       Date:  1976-08-20       Impact factor: 47.728

  5 in total
  7 in total

1.  In vitro adaptability of Plasmodium falciparum to different fresh serum alternatives.

Authors:  Chandrajit Dohutia; Pradyumna K Mohapatra; Dibya Ranjan Bhattacharyya; Kabita Gogoi; Khukumoni Bora; Basanta K Goswami
Journal:  J Parasit Dis       Date:  2016-06-30

Review 2.  Recent advances in malaria parasite cultivation and their application to studies on host-parasite relationships: a review.

Authors:  P I Trigg
Journal:  Bull World Health Organ       Date:  1985       Impact factor: 9.408

3.  In vitro culture and drug sensitivity assay of Plasmodium falciparum with nonserum substitute and acute-phase sera.

Authors:  P Ringwald; F S Meche; J Bickii; L K Basco
Journal:  J Clin Microbiol       Date:  1999-03       Impact factor: 5.948

4.  Serum-free cultivation of Plasmodium falciparum gametocytes in vitro.

Authors:  A Lingnau; G Margos; W A Maier; H M Seitz
Journal:  Parasitol Res       Date:  1993       Impact factor: 2.289

5.  Studies on serum requirements for the cultivation of Plasmodium falciparum. 2. Medium enrichment.

Authors:  A A Divo; J B Jensen
Journal:  Bull World Health Organ       Date:  1982       Impact factor: 9.408

6.  African serum interference in the determination of chloroquine sensitivity in Plasmodium falciparum.

Authors:  J M Carlin; J A Vande Waa; J B Jensen; M A Akood
Journal:  Z Parasitenkd       Date:  1984

7.  Continuous Cultures of Plasmodium Falciparum Established in Tanzania from Patients with Acute Malaria.

Authors:  Florence Urio; Matilda Mkombachepa; Gration Rwegasira; Twilumba Makene; Billy Ngasala; Teddy Mselle; Julie Makani; Lucio Luzzatto
Journal:  Mediterr J Hematol Infect Dis       Date:  2021-05-01       Impact factor: 2.576

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.